BET inhibitor apabetalone suppresses the fibrotic activation of cardiac fibroblasts associated with heart dysfunction
- DOI
- 10.1016/j.biopha.2026.119876
- Published
- 2026-10
- Container
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2026.119876,
title = {BET inhibitor apabetalone suppresses the fibrotic activation of cardiac fibroblasts associated with heart dysfunction},
author = {Sylwia Wasiak and Dean Gilham and Li Fu and Laura M. Tsujikawa and Agostina Carestia and Christopher D. Sarsons and Guoqi Teng and Jeannine D. Turnbull and Ali Fatehi Hassanabad and Michael Sweeney and Paul W.M. Fedak and Ewelina Kulikowski},
year = {2026},
journal = {Biomedicine \& Pharmacotherapy},
doi = {10.1016/j.biopha.2026.119876},
url = {https://doi.org/10.1016/j.biopha.2026.119876}
}RIS
TY - JOUR TI - BET inhibitor apabetalone suppresses the fibrotic activation of cardiac fibroblasts associated with heart dysfunction AU - Sylwia Wasiak AU - Dean Gilham AU - Li Fu AU - Laura M. Tsujikawa AU - Agostina Carestia AU - Christopher D. Sarsons AU - Guoqi Teng AU - Jeannine D. Turnbull AU - Ali Fatehi Hassanabad AU - Michael Sweeney AU - Paul W.M. Fedak AU - Ewelina Kulikowski PY - 2026 JO - Biomedicine & Pharmacotherapy DO - 10.1016/j.biopha.2026.119876 UR - https://doi.org/10.1016/j.biopha.2026.119876 ER -
APA
Wasiak, S., Gilham, D., Fu, L., Tsujikawa, L. M., Carestia, A., Sarsons, C. D., Teng, G., Turnbull, J. D., Hassanabad, A. F., Sweeney, M., Fedak, P. W., & Kulikowski, E. (2026). BET inhibitor apabetalone suppresses the fibrotic activation of cardiac fibroblasts associated with heart dysfunction. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2026.119876
Source records
- crossref · retrieved 2026-09-26T09:42:48.731Z